<code id='83F9EEC5BD'></code><style id='83F9EEC5BD'></style>
    • <acronym id='83F9EEC5BD'></acronym>
      <center id='83F9EEC5BD'><center id='83F9EEC5BD'><tfoot id='83F9EEC5BD'></tfoot></center><abbr id='83F9EEC5BD'><dir id='83F9EEC5BD'><tfoot id='83F9EEC5BD'></tfoot><noframes id='83F9EEC5BD'>

    • <optgroup id='83F9EEC5BD'><strike id='83F9EEC5BD'><sup id='83F9EEC5BD'></sup></strike><code id='83F9EEC5BD'></code></optgroup>
        1. <b id='83F9EEC5BD'><label id='83F9EEC5BD'><select id='83F9EEC5BD'><dt id='83F9EEC5BD'><span id='83F9EEC5BD'></span></dt></select></label></b><u id='83F9EEC5BD'></u>
          <i id='83F9EEC5BD'><strike id='83F9EEC5BD'><tt id='83F9EEC5BD'><pre id='83F9EEC5BD'></pre></tt></strike></i>

          hotspot

          hotspot

          author:hotspot    Page View:39639
          Diversity in clinical trials concept
          Adobe

          The persistent lack of diversity among participants in clinical trials is a critical issue that is harming both populations that have long been left out of pivotal medical studies and the entire biomedical research enterprise, according to the authors of a report released Tuesday by the National Academies of Sciences, Engineering and Medicine.

          Describing the need to move away from trials that focus largely on white men as “urgent,” the report’s authors called for a paradigm shift that gives less power to institutions that fund and conduct clinical research and more to communities under study. The sternly worded report said funding to include and recruit more diverse participants should be a priority that is enforced and said such investments could eventually lead to massive cost savings as the nation’s health disparities are reduced.

          advertisement

          “An equitable clinical research enterprise would include trials and studies that match the demographics of the disease burden under study,” the report said. “However, we remain far from achieving this goal.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more
          Intercept Pharmaceuticals sells itself for less than $1 billion
          Intercept Pharmaceuticals sells itself for less than $1 billion

          AdobeInterceptPharmaceuticals,afirmwhosetreatmentforaprevalentliverdiseaseoncemadeitthehotteststocki

          read more
          Dobbs anniversary: the lost opportunity of abortion as health care
          Dobbs anniversary: the lost opportunity of abortion as health care

          NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

          read more

          STAT series 'Denied by AI' wins major journalism prizes

          MikeReddyforSTATDearReaders,PleasebearwithmeasIbragabouttwoofSTAT’smostaccomplished(andhumble)report